Relief-PE
NDC 50332-0153, ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE, tablet, coated, from HART Health.
- Product NDC
- 50332-0153
- Status
- Listed
- Labeler
- HART Health
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50332-0153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN325 mg/1
- PHENYLEPHRINE HYDROCHLORIDE5 mg/1
- CHLORPHENIRAMINE MALEATE2 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50332-0153-4 | 50332015304 | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4) |
| 50332-0153-7 | 50332015307 | 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50332-0153 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50332-0153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50332-0153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.